The Guidance would support biologic drug competition, increase patient access to biosimilars and lower healthcare costs for patients, the FTC’s comment says.
The new service will empower patients to request delivery for select prescriptions through the Kroger app as soon as their medications are ready for pick up.
The collaboration aims to address barriers in decentralized clinical trial access and conduct trials over a five-year period, valued up to $100 million for the D-COHRe program.
